dc.contributor.author |
Moonmuang S. |
|
dc.contributor.author |
Saoin S. |
|
dc.contributor.author |
Chupradit K. |
|
dc.contributor.author |
Sakkhachornphop S. |
|
dc.contributor.author |
Israsena N. |
|
dc.contributor.author |
Rungsiwiwut R. |
|
dc.contributor.author |
Tayapiwatana C. |
|
dc.date.accessioned |
2021-04-05T03:05:37Z |
|
dc.date.available |
2021-04-05T03:05:37Z |
|
dc.date.issued |
2018 |
|
dc.identifier.issn |
1448463 |
|
dc.identifier.other |
2-s2.0-85052957177 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/12760 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052957177&doi=10.1042%2fBSR20181109&partnerID=40&md5=bca53f2880a16d21efb8f71e053657a0 |
|
dc.description.abstract |
Lentiviral vectors have emerged as the most efficient system to stably transfer and insert genes into cells. By adding a tetracycline (Tet)-inducible promoter, transgene expression delivered by a lentiviral vector can be expressed whenever needed and halted when necessary. Here we have constructed a doxycycline (Dox)-inducible lentiviral vector which efficiently introduces a designed zinc finger protein, 2-long terminal repeat zinc-finger protein (2LTRZFP), into hematopoietic cell lines and evaluated its expression in pluripotent stem cells. As a result this lentiviral inducible system can regulate 2LTRZFP expression in the SupT1 T-cell line and in pluripotent stem cells. Using this vector, no basal expression was detected in the T-cell line and its induction was achieved with low Dox concentrations. Remarkably, the intracellular regulatory expression of 2LTRZFP significantly inhibited HIV-1 integration and replication in HIV-inoculated SupT1 cells. This approach could provide a potential tool for gene therapy applications, which efficiently control and reduce the side effect of therapeutic genes expression. © 2018 The Author(s). |
|
dc.subject |
doxycycline |
|
dc.subject |
lentivirus vector |
|
dc.subject |
protein 2LTR |
|
dc.subject |
tetracycline |
|
dc.subject |
unclassified drug |
|
dc.subject |
zinc finger protein |
|
dc.subject |
doxycycline |
|
dc.subject |
tetracycline |
|
dc.subject |
zinc finger protein |
|
dc.subject |
antiviral activity |
|
dc.subject |
Article |
|
dc.subject |
controlled study |
|
dc.subject |
gene expression |
|
dc.subject |
gene therapy |
|
dc.subject |
hematopoietic cell line |
|
dc.subject |
Human immunodeficiency virus 1 infection |
|
dc.subject |
nonhuman |
|
dc.subject |
pluripotent stem cell |
|
dc.subject |
protein expression |
|
dc.subject |
protein stability |
|
dc.subject |
SUP-T1 cell line |
|
dc.subject |
T lymphocyte |
|
dc.subject |
therapy effect |
|
dc.subject |
virus DNA cell DNA interaction |
|
dc.subject |
virus induction |
|
dc.subject |
virus interference |
|
dc.subject |
virus replication |
|
dc.subject |
dose response |
|
dc.subject |
drug effect |
|
dc.subject |
gene expression regulation |
|
dc.subject |
gene vector |
|
dc.subject |
genetics |
|
dc.subject |
HEK293 cell line |
|
dc.subject |
human |
|
dc.subject |
Human immunodeficiency virus 1 |
|
dc.subject |
Human immunodeficiency virus infection |
|
dc.subject |
Lentivirus |
|
dc.subject |
long terminal repeat |
|
dc.subject |
pathogenicity |
|
dc.subject |
physiology |
|
dc.subject |
procedures |
|
dc.subject |
transgene |
|
dc.subject |
virology |
|
dc.subject |
virus DNA cell DNA interaction |
|
dc.subject |
Dose-Response Relationship, Drug |
|
dc.subject |
Doxycycline |
|
dc.subject |
Gene Expression Regulation |
|
dc.subject |
Genetic Therapy |
|
dc.subject |
Genetic Vectors |
|
dc.subject |
HEK293 Cells |
|
dc.subject |
HIV Infections |
|
dc.subject |
HIV Long Terminal Repeat |
|
dc.subject |
HIV-1 |
|
dc.subject |
Humans |
|
dc.subject |
Lentivirus |
|
dc.subject |
Pluripotent Stem Cells |
|
dc.subject |
Tetracycline |
|
dc.subject |
Transgenes |
|
dc.subject |
Virus Integration |
|
dc.subject |
Zinc Fingers |
|
dc.title |
Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Bioscience Reports. Vol 38, No.5 (2018) |
|
dc.identifier.doi |
10.1042/BSR20181109 |
|